| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785074 | Brachytherapy | 2018 | 8 Pages |
Abstract
This study of over 8,000 patients demonstrates that adjuvant RT confers a survival benefit in Stage II endometrial cancer and supports the continued use of RT in these patients. BT alone may be reasonable in carefully selected patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Andrzej P. Wojcieszynski, Craig R. Hullett, Erin E. Medlin, Neil K. Taunk, Jacob E. Shabason, Jeffrey V. Brower, Shuai Chen, Justin E. Bekelman, Lisa M. Barroilhet, Kristin A. Bradley,